104
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Maculopathy Secondary to Pentosan Polysulfate Use: A Single-Center Experience

, , &
Pages 513-519 | Published online: 11 Feb 2021

References

  • Berry SH, Elliott MN, Suttorp M, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540–544. doi:10.1016/j.juro.2011.03.132
  • Chancellor MB, Yoshimura N. Treatment of interstitial cystitis. Urology. 2004;63(3):85–92. doi:10.1016/j.urology.2003.10.034
  • Anderson VR, Perry CM. Pentosan polysulfate. Drugs. 2006;66(6):821–835. doi:10.2165/00003495-200666060-00006
  • Pearce WA, Chen R, Jain N. Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium. Ophthalmology. 2018;125(11):1793–1802. doi:10.1016/j.ophtha.2018.04.026
  • Barnes AC, Hanif AM, Jain N. Pentosan polysulfate maculopathy versus inherited macular dystrophies: comparative assessment with multimodal imaging. Ophthalmol Retina. 2020;4(12):1196–1201. doi:10.1016/j.oret.2020.05.008
  • Wang D, Au A, Gunnemann F, et al. Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis. Can J Ophthalmol. 2020;55(2):116–125. doi:10.1016/j.jcjo.2019.12.001
  • Vora RA, Patel AP, Melles R. Prevalence of maculopathy associated with long-term pentosan polysulfate therapy. Ophthalmology. 2020;27(6):835–836. doi:10.1016/j.ophtha.2020.01.017
  • Greenlee T, Hom G, Conti T, Babiuch AS, Singh R. Re: pearce et al.: pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium (Ophthalmology. 2018; 125 (11):1793-1802). Ophthalmology. 2019;126(7):e51. doi:10.1016/j.ophtha.2018.12.037
  • Hanif AM, Armenti ST, Taylor SC, et al. Phenotypic spectrum of pentosan polysulfate sodium–associated maculopathy: a multicenter study. JAMA Ophthalmol. 2019;137(11):1275. doi:10.1001/jamaophthalmol.2019.3392
  • Hanif AM, Shah R, Yan J, et al. Strength of association between pentosan polysulfate and a novel maculopathy. Ophthalmology. 2019;126(10):1464–1466. doi:10.1016/j.ophtha.2019.04.024
  • Mogica JAP, De EJB. Pentosan polysulfate maculopathy: what urologists should know in 2020. Urology. 2020;S0090-4295(20)31240-1.
  • Ludwig CA, Vail D, Callaway NF, Pasricha MV, Moshfeghi DM. Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States. Ophthalmology. 2020;127(4):535–543. doi:10.1016/j.ophtha.2019.10.036
  • Jain N, Li AL, Yu Y, VanderBeek BL. Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort. B J Ophthalmol. 2020;104(8):1093–1097. doi:10.1136/bjophthalmol-2019-314765
  • Hadad A, Helmy O, Leeman S, Schaal S, Novel Multimethod A. A novel multimethod image analysis to quantify pentosan polysulfate sodium retinal toxicity. Ophthalmology. 2020;127(3):429–431. doi:10.1016/j.ophtha.2019.10.013
  • Huckfeldt RM, Vavvas DG. Progressive maculopathy after discontinuation of pentosan polysulfate sodium. Ophthalmic Surg Lasers Imaging Retina. 2019;50(10):656–659. doi:10.3928/23258160-20191009-10
  • Shah R, Simonett JM, Lyons RJ, Rao RC, Pennesi ME, Jain N. Disease course in patients with pentosan polysulfate sodium-associated maculopathy after drug cessation. JAMA Ophthalmol. 2020;138(8):894–900. doi:10.1001/jamaophthalmol.2020.2349
  • Lyons RJ, Ahmad S, Ansari S, Foote JE, Jain N. Pentosan polysulfate-associated macular disease in patients with interstitial cystitis. Obstet Gynecol. 2020;135(5):1091–1094. doi:10.1097/AOG.0000000000003794